StonvexLoading…
StonvexStonvexStonvexCore line items from CRL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-28 | Annual 2025 2025-12-27 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $995.83M | $4.02B | $3.02B | $2.02B |
Operating Income | $119.90M | $25.16M | $308.60M | $174.80M |
Net Income | $-14.84M | $-144.34M | $132.22M | $77.80M |
EPS (Diluted) | $-0.30 | $-2.91 | $2.65 | $1.55 |
Total Assets | $7.73B | $7.14B | $7.51B | $7.56B |
Total Liabilities | $4.74B | $3.92B | $4.06B | $4.16B |
Cash & Equivalents | $191.83M | $213.77M | $207.10M | $182.82M |
Free Cash Flow OCF − CapEx | $-14.83M | $518.49M | $459.92M | $281.68M |
Shares Outstanding | 48.17M | 49.22M | 49.22M | 49.21M |